Studykik

Studykik company information, Employees & Contact Information

Explore related pages

Related company profiles:

StudyKIK is a full service patient recruitment and retention technology company that leverages technology, social media, and indication-specific expertise to ensure study timelines and sponsor budgets are met. Since its inception, StudyKIK has reached over 6 million patients and connected over 3.1 million patients to studies. StudyKIK provides recruitment and technology solutions for patients, sites, CROs, and sponsors as well as customized app technologies to assist with patient retention once patients are randomized. As a result, StudyKIK is the global leader in patient recruitment and retention strategy and implementation.

Company Details

Employees
81
Founded
-
Address
1315 Lincoln Blvd,
Phone
877.627.2509
Email
in****@****kik.com
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
Santa Monica, California
Looking for a particular Studykik employee's phone or email?

Studykik Questions

News

Syneos buys StudyKIK in latest move to grow decentralized trials business - BioXconomy

Syneos buys StudyKIK in latest move to grow decentralized trials business BioXconomy

Syneos Health acquires StudyKIK to boost tech-enabled solutions offering - Clinical Trials Arena

Syneos Health acquires StudyKIK to boost tech-enabled solutions offering Clinical Trials Arena

Syneos Health Acquires StudyKIK - GlobeNewswire

Syneos Health Acquires StudyKIK GlobeNewswire

Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK - Contract Pharma

Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK Contract Pharma

Life Line Screening Appoints Matt Miller as Chief Executive Officer - Business Wire

Life Line Screening Appoints Matt Miller as Chief Executive Officer Business Wire

Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout - The AI Journal

Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout The AI Journal

Top Studykik Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant